Citations (178)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (25)
Fereshteh Hozoorbakhsh, Mozhgan Ghiasian, Fereshte Ghandehari, Zarrindokht Emami-Karvani & Maryam Khademi Dehkordi. (2023) An immunoinformatic approach employing molecular docking and molecular dynamics simulation for evaluation of l-asparaginase produced by Bacillus velezensis. Journal of Biomolecular Structure and Dynamics 41:18, pages 9057-9071.
Read now
Read now
Amani Alqahtani, Diala Alhousari, Amir Ali, George Yaghmour, Etan Orgel, Emily Curran, Wendy Stock, Deepa Bhojwani & Houda Alachkar. (2023) Asparaginase toxicity in Hispanic adult and pediatric patients with acute lymphoblastic leukemia: current understanding. Expert Opinion on Drug Metabolism & Toxicology 19:6, pages 357-366.
Read now
Read now
Melissa Sandley & Jonathan Angus. (2023) Asparaginase therapy in patients with acute lymphoblastic leukemia: expert opinion on use and toxicity management. Leukemia & Lymphoma 64:4, pages 776-787.
Read now
Read now
Krishna R Juluri, Chloe Siu & Ryan D Cassaday. (2022) Asparaginase in the Treatment of Acute Lymphoblastic Leukemia in Adults: Current Evidence and Place in Therapy. Blood and Lymphatic Cancer: Targets and Therapy 12, pages 55-79.
Read now
Read now
YeeAnn Chen, Kaitlyn Buhlinger, Anthony J. Perissinotti, Allison J. Schepers, Lydia Benitez, Jessica Auten, Sheh-Li Chen, Dale L. Bixby, Patrick W. Burke, Kristen M. Pettit & Bernard L. Marini. (2022) Solving coagulation conundrums: comparing prophylaxis strategies in adult patients receiving PEG-asparaginase. Leukemia & Lymphoma 63:11, pages 2663-2670.
Read now
Read now
Cynthia Bender, Luke Maese, Maria Carter-Febres & Anupam Verma. (2021) Clinical Utility of Pegaspargase in Children, Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia: A Review. Blood and Lymphatic Cancer: Targets and Therapy 11, pages 25-40.
Read now
Read now
Ryan J. Daley, Sridevi Rajeeve, Charlene C. Kabel, Jeremy J. Pappacena, Sarah E. Stump, Jessica A. Lavery, Martin S. Tallman, Mark B. Geyer & Jae H. Park. (2021) Tolerability and toxicity of pegaspargase in adults 40 years and older with acute lymphoblastic leukemia. Leukemia & Lymphoma 62:1, pages 176-184.
Read now
Read now
Saveria Capria, Matteo Molica, Sara Mohamed, Simona Bianchi, Maria Luisa Moleti, Silvia Maria Trisolini, Sabina Chiaretti & Anna Maria Testi. (2020) A review of current induction strategies and emerging prognostic factors in the management of children and adolescents with acute lymphoblastic leukemia. Expert Review of Hematology 13:7, pages 755-769.
Read now
Read now
Benjamin A. Derman, Mitchell Streck, Joseph Wynne, Trevor N. Christ, Emily Curran, Wendy Stock & Randall W. Knoebel. (2020) Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia. Leukemia & Lymphoma 61:3, pages 614-622.
Read now
Read now
Claudia Lanvers-Kaminsky, Andreas Niemann, Maria Eveslage, Joachim Beck, Thomas Köhnke, Sonja Martin, Maike de Wit, Bernd Spriewald, Holger Hauspurg, Dieter Hoelzer, Joachim Boos & Nicola Gökbuget. (2020) Asparaginase activities during intensified treatment with pegylated E. coli asparaginase in adults with newly-diagnosed acute lymphoblastic leukemia. Leukemia & Lymphoma 61:1, pages 138-145.
Read now
Read now
Bernard L. Marini, Julia Brown, Lydia Benitez, Emily Walling, Raymond J. Hutchinson, Rajen Mody, Rama Jasty Rao, Lynn Slagle, Lauren Bishop, Kristen Pettit, Dale L. Bixby, Patrick W. Burke & Anthony J. Perissinotti. (2019) A single-center multidisciplinary approach to managing the global Erwinia asparaginase shortage. Leukemia & Lymphoma 60:12, pages 2854-2868.
Read now
Read now
Vadim S. Pokrovsky & Denis Vinnikov. (2019) Defining the toxicity of current regimens for extranodal NK/T cell lymphoma: a systematic review and metaproportion. Expert Review of Anticancer Therapy 19:1, pages 93-104.
Read now
Read now
Rachael R. Schulte, Manasi V. Madiwale, Allyson Flower, Jessica Hochberg, Michael J. Burke, Jennifer L. McNeer, Adam DuVall & Archie Bleyer. (2018) Levocarnitine for asparaginase-induced hepatic injury: a multi-institutional case series and review of the literature. Leukemia & Lymphoma 59:10, pages 2360-2368.
Read now
Read now
Josep-Maria Ribera, Mireia Morgades, Pau Montesinos, Rodrigo Martino, Pere Barba, Beatriz Soria, Arancha Bermúdez, María-José Moreno, José González-Campos, Susana Vives, Cristina Gil, Eugenia Abella, Ramon Guàrdia, Daniel Martínez-Carballeira, Pilar Martínez-Sánchez, María-Luz Amigo, Santiago Mercadal, Alfons Serrano, Aurelio López-Martínez, Ferran Vall-Llovera, María-José Sánchez-Sánchez, María-Jesús Peñarrubia, María Calbacho, Jose-Angel Méndez, Juan Bergua, Antonia Cladera, Mar Tormo, Daniel García-Belmonte, Evarist Feliu, Juana Ciudad & Alberto Orfao. (2018) Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia. Leukemia & Lymphoma 59:7, pages 1634-1643.
Read now
Read now
Ibrahim Aldoss & Anthony S. Stein. (2018) Advances in adult acute lymphoblastic leukemia therapy. Leukemia & Lymphoma 59:5, pages 1033-1050.
Read now
Read now
Caitlin R. Rausch, Bernard L. Marini, Lydia L. Benitez, Allison Elias, Patrick W. Burke, Dale Bixby & Anthony J. Perissinotti. (2018) PEGging down risk factors for peg-asparaginase hepatotoxicity in patients with acute lymphoblastic leukemia. Leukemia & Lymphoma 59:3, pages 617-624.
Read now
Read now
Deepesh Lad, Arihant Jain & Subhash Varma. (2017) Complications and management of coagulation disorders in leukemia patients. Blood and Lymphatic Cancer: Targets and Therapy 7, pages 61-72.
Read now
Read now
Jason N. Barreto, Kristen B. McCullough, Candy S. Peskey, Ross A. Dierkhising, Kristin C. Mara, Michelle A. Elliott, Dennis A. Gastineau, Aref Al-Kali, Naseema Gangat, Louis Letendre, William J. Hogan, Mark R. Litzow & Mrinal M. Patnaik. (2017) Safety and feasibility of lower antithrombin replacement targets in adult patients with hematological malignancies receiving asparaginase therapy. Leukemia & Lymphoma 58:11, pages 2588-2597.
Read now
Read now
Michael J. Burke & Susan R. Rheingold. (2017) Differentiating hypersensitivity versus infusion-related reactions in pediatric patients receiving intravenous asparaginase therapy for acute lymphoblastic leukemia. Leukemia & Lymphoma 58:3, pages 540-551.
Read now
Read now
Sarah McKillop, Cynthia Wu, Aisha Bruce & Joseph Brandwein. (2016) Optimal management of venous thromboembolism in adolescent and young adult oncology patients. Clinical Oncology in Adolescents and Young Adults 6, pages 39-49.
Read now
Read now
Xavier Thomas & Caroline Le Jeune. (2016) Treating adults with acute lymphocytic leukemia: new pharmacotherapy options. Expert Opinion on Pharmacotherapy 17:17, pages 2319-2330.
Read now
Read now
Abraham Chang, Michelle Kim, Maggie Seyer & Samit Patel. (2016) Allergic reactions associated with pegaspargase in adults. Leukemia & Lymphoma 57:7, pages 1665-1668.
Read now
Read now
Nobuko Hijiya & Inge M. van der Sluis. (2016) Asparaginase-associated toxicity in children with acute lymphoblastic leukemia. Leukemia & Lymphoma 57:4, pages 748-757.
Read now
Read now
Lisa Figueiredo, Peter D. Cole & Richard A. Drachtman. (2016) Asparaginase Erwinia chrysanthemi as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who have developed hypersensitivity to E. coli-derived asparaginase. Expert Review of Hematology 9:3, pages 227-234.
Read now
Read now
Sara Bigliardi, Monica Morselli, Leonardo Potenza, Valeria Coluccio, Monica Maccaferri, Ambra Paolini, Elisabetta Colaci, Valeria Fantuzzi, Laura Faglioni, Francesco Soci, Vincenzo Nasillo, Andrea Messerotti, Paola Pedrazzi, Marco Marietta, Mario Luppi & Fabio Forghieri. (2015) Safety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic leukemia: a retrospective monocenter study. Leukemia & Lymphoma 56:3, pages 770-773.
Read now
Read now
Articles from other publishers (153)
Ryan D. Cassaday. (2023) Asparaginase dosing for obese patients with acute lymphoblastic leukemia and factors that contribute to outcomes. Best Practice & Research Clinical Haematology 36:4, pages 101519.
Crossref
Crossref
Wojciech Lizurej, Łukasz Mazurkiewicz, Michał Kowalski, Sylwia Szydłowska, Michał Wyrzykowski & Krzysztof Lewandowski. (2023) Superior sagittal sinus thrombosis in the course of mixed phenotype acute leukaemia treated with acute lymphoblastic leukaemia-like therapy—a case report. Thrombosis Journal 21:1.
Crossref
Crossref
Renato Bassan, Sabina Chiaretti, Irene Della Starza, Orietta Spinelli, Alessandra Santoro, Francesca Paoloni, Monica Messina, Loredana Elia, Maria Stefania De Propris, Anna Maria Scattolin, Ernesta Audisio, Laura Marbello, Erika Borlenghi, Patrizia Zappasodi, Elisa Mauro, Giovanni Martinelli, Daniele Mattei, Nicola Fracchiolla, Monica Bocchia, Paolo De Fabritiis, Massimiliano Bonifacio, Anna Candoni, Vincenzo Cassibba, Paolo Di Bartolomeo, Giancarlo Latte, Silvia Trappolini, Anna Guarini, Antonella Vitale, Paola Fazi, Alfonso Piciocchi, Alessandro Rambaldi & Robin Foà. (2023) Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial. Blood Advances 7:16, pages 4448-4461.
Crossref
Crossref
Loai Shakerdi & Aidan Ryan. (2023) Drug-induced hyperammonaemia. Journal of Clinical Pathology 76:8, pages 501-509.
Crossref
Crossref
Taylor D. Coe-Eisenberg, Anthony J. Perissinotti, Bernard L. Marini, Kristen M. Pettit, Dale L. Bixby, Patrick W. Burke & Lydia Benitez. (2023) Evaluating the efficacy and toxicity of dose adjusted pegylated L-asparaginase in combination with therapeutic drug monitoring. Annals of Hematology.
Crossref
Crossref
O. A. Aleshina, E. S. Kotova, G. A. Isinova, M. E. Grishunina, J. V. Sveshnikova, K. D. Kaplanov, S. N. Bondarenko, E. E. Zinina, Yu. A. Chabaeva & E. N. Parovichnikova. (2023) The use of pegaspargase in adult Ph-negative acute lymphoblastic leukemia patients in the treatment according to the all-2016 protocol. Russian journal of hematology and transfusiology 68:2, pages 166-181.
Crossref
Crossref
İsmet Bulut & Zeynep Yegin Katran. (2023) Hypersensitivity Reaction and Rapid Drug Desensitization with Chemotherapeutics: A Tertiary Reference Center Experiences. International Archives of Allergy and Immunology, pages 1-7.
Crossref
Crossref
Angela Lee, Irem Eldem, Burak Altintas, Hoanh Nguyen, Daniel Willis, Rachel Langley & Marwan Shinawi. (2023) Treatment and outcomes of symptomatic hyperammonemia following asparaginase therapy in children with acute lymphoblastic leukemia. Molecular Genetics and Metabolism 139:3, pages 107627.
Crossref
Crossref
Yuchen Liu & Vu H. Duong. (2023) Approach to the Treatment of Philadelphia Chromosome-Negative B-cell ALL in Older Adults: Is Age Becoming just a Number?. Current Hematologic Malignancy Reports 18:3, pages 68-74.
Crossref
Crossref
Dhaarani Jayaraman, Latha M. Sneha, Gracelin Jeyarani, Alekhya Somayajula, Balaji Thiruvengadam Kothandam, Julius Xavier Scott & A Gadekar. (2023) Experience with Generic Pegylated L-asparaginase in Children with Acute Lymphoblastic Leukemia from a Tertiary Care Oncology Center in South India. South Asian Journal of Cancer.
Crossref
Crossref
Salvatore Crisafulli, Paola Maria Cutroneo, Nicoletta Luxi, Andrea Fontana, Carmen Ferrajolo, Pasquale Marchione, Laura Sottosanti, Giovanna Zanoni, Ugo Moretti, Silvia Franzè, Paola Minghetti & Gianluca Trifirò. (2023) Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System. Drug Safety 46:4, pages 343-355.
Crossref
Crossref
Audrey Grain, Fanny Rialland-Battisti, Patrice Chevallier, Nicolas Blin, Jean-Hugues Dalle, Gérard Michel, Nathalie Dhédin, Regis Peffault de Latour, Cécile Pochon, Ibrahim Yakoub-Agha, Yves Bertrand, Anne Sirvent, Charlotte Jubert, Edouard Forcade, Ana Berceanu, Virginie Gandemer, Pascale Schneider, Jacques-Olivier Bay, Pierre-Simon Rohrlich, Eolia Brissot, Catherine Paillard, Dominique Plantaz, Stéphanie Nguyen Quoc, Fanny Gonzales, Natacha Maillard, Lucie Planche & André Baruchel. (2022) Hematopoietic stem cell transplantation for acute lymphoblastic leukemia: why do adolescents and young adults outcomes differ from those of children? A retrospective study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC). Journal of Cancer Research and Clinical Oncology 149:4, pages 1473-1483.
Crossref
Crossref
Emiliano Barbieri, Stefano Pozzi, Roberta Gelmini, Luca Roncati, Monica Maccaferri, Leonardo Potenza, Roberto Marasca, Mario Luppi & Giovanna Leonardi. (2022) PEG-Asparaginase Single-Agent Rescue in an Advanced Case of Monomorphic Epitheliotropic Intestinal T Cell Lymphoma. Journal of Gastrointestinal Cancer 54:1, pages 304-308.
Crossref
Crossref
N.V. Bronina, I.O. Shchederkina, A.Yu. Polushin, E.V. Seliverstova, Y.B. Skiba, K.I. Kirgizov, G.O. Bronin & I.A. Voznyuk. (2023) Posterior reversible encephalopathy syndrome in children with hematological diseases. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 123:9, pages 33.
Crossref
Crossref
Lesleigh Abbott, Maia Claveau, Ken Tang, Jameason Cameron & Genevieve Goulet. (2022)
The association of age and adverse events of
PEG
‐asparaginase in a pediatric tertiary care hospital; a retrospective review
. European Journal of Haematology 110:1, pages 32-39.
Crossref
Crossref
Hoda Pourhassan, Dan Douer, Vinod Pullarkat & Ibrahim Aldoss. (2022) Asparaginase: How to Better Manage Toxicities in Adults. Current Oncology Reports 25:1, pages 51-61.
Crossref
Crossref
Jacob R. Greenmyer, Kirk D. Wyatt, Vilmarie Rodriguez, Aneel A. Ashrani & Deepti Warad. (2022) Management Practices for Asparaginase-associated Coagulopathy: A Survey of Pediatric Oncologists. Journal of Pediatric Hematology/Oncology 44:8, pages e1023-e1028.
Crossref
Crossref
Marzia Defina, Davide Lazzarotto, Fabio Guolo, Paola Minetto, Nicola Stefano Fracchiolla, Fabio Giglio, Fabio Forghieri, Antonella Vitale, Sabina Chiaretti, Cristina Papayannidis, Matteo Piccini, Antonino Mulè, Monica Bocchia, Matteo Leoncin, Carmela Gurrieri, Lara Aprile, Monia Lunghi, Massimiliano Bonifacio, Crescenza Pasciolla, Marco Cerrano, Monica Fumagalli, Robin Foà & Anna Candoni. (2022) Levocarnitine supplementation for asparaginase-induced hepatotoxicity in adult acute lymphoblastic leukemia patients: A multicenter observational study of the campus all group. Leukemia Research 122, pages 106963.
Crossref
Crossref
Marilyne Poirée, Florent Neumann, Caroline Thomas, Pauline Simon, Anne France Ray Lunven, Dominique Plantaz, Sandrine Thouvenin Doulet & Marion Strullu. (2022) Prise en charge des toxicités de la pégaspargase (hors anomalies de la coagulation). Recommandations du comité leucémie de la Société française de lutte contre les cancers de l’enfant et de l’adolescent. Bulletin du Cancer 109:11, pages 1125-1131.
Crossref
Crossref
Calogero Vetro, Andrea Duminuco, Lucia Gozzo, Cinzia Maugeri, Marina Parisi, Serena Brancati, Laura Longo, Daniela Cristina Vitale, Giovanni Luca Romano, Roberto Ciuni, Elisa Mauro, Paolo Fabio Fiumara, Giuseppe Alberto Maria Palumbo, Filippo Drago & Francesco Di Raimondo. (2022) Pegylated Asparaginase‐Induced Liver Injury: A Case‐Based Review and Data From Pharmacovigilance. The Journal of Clinical Pharmacology 62:9, pages 1142-1150.
Crossref
Crossref
Randal K Buddington, Karyl K Buddington & Scott C. Howard. (2022) Multiple Asparaginase Infusions Cause Increasingly Severe Acute Hyperammonemia. Medical Sciences 10:3, pages 43.
Crossref
Crossref
Ewelina Truszkowska, Marta Andrzejewska, Cyntia Szymańska, Agnieszka Wziątek & Katarzyna Derwich. (2022) Case Report: Brentuximab Vedotin Associated Acute Pancreatitis in a Pediatric Hodgkin Lymphoma Patient: Case Report and Literature Review. Pathology and Oncology Research 28.
Crossref
Crossref
Rajashekar Sindhu & Haravey K. Manonmani. (2022) L-asparaginase-mediated Therapy in L-asparagine Auxotrophic Cancers: A Review. Anti-Cancer Agents in Medicinal Chemistry 22:13, pages 2393-2410.
Crossref
Crossref
Koushik Handattu, Lokesh K. Sharma, Kalasekhar Vijayasekharan, Vasudeva Bhat K.Shrikiran Aroor & Siddhnath Sudhanshu. (2022) Drug Induced Diabetes Mellitus in Pediatric Acute Lymphoblastic Leukemia: Approach to Diagnosis and Management. Journal of Pediatric Hematology/Oncology 44:6, pages 273-279.
Crossref
Crossref
Chi-Bo Chen, Hsiu-Hao Chang, Shu-Wei Chou, Yung-Li Yang, Meng-Yao Lu, Shiann-Tarng Jou, Huey-Ling Chen, Yen-Hsuan Ni, Dong-Tsamn Lin, Mei-Hwei Chang & Jia-Feng Wu. (2021) Acute pancreatitis in children with acute lymphoblastic leukemia correlates with L-asparaginase dose intensity. Pediatric Research 92:2, pages 459-465.
Crossref
Crossref
Sharon Wu, Mengxi Wang, Amani Alqahtani, Mimi Lou, Wendy Stock, Deepa Bhojwani & Houda Alachkar. (2022) Hispanic ethnicity and the rs4880 variant in SOD2 are associated with elevated liver enzymes and bilirubin levels in children receiving asparaginase-containing chemotherapy for acute lymphoblastic leukemia. Biomedicine & Pharmacotherapy 150, pages 113000.
Crossref
Crossref
Doaa B. Darwesh, Yahya S. Al-Awthan, Imadeldin Elfaki, Salem A. Habib, Tarig M. Alnour, Ahmed B. Darwish & Magdy M. Youssef. (2022)
Anticancer Activity of Extremely Effective Recombinant L-Asparaginase from
Burkholderia pseudomallei
. Journal of Microbiology and Biotechnology 32:5, pages 551-563.
Crossref
Crossref
Dan Douer, Nicola Gökbuget, Wendy Stock & Nicolas Boissel. (2022) Optimizing use of L-asparaginase–based treatment of adults with acute lymphoblastic leukemia. Blood Reviews 53, pages 100908.
Crossref
Crossref
Craig J. Beavers, Jo E. Rodgers, Aaron J. Bagnola, Theresa M. Beckie, Umberto Campia, Katherine E. Di Palo, Tochi M. Okwuosa, Eugene R. Przespolewski & Susan Dent. (2022) Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association. Circulation 145:15.
Crossref
Crossref
Jing Yang, Xiangyun Guo, Sutang Guo, Hongxia Yan, Limin Chai, Yimeng Guo, Zhenhua LiZhiying Hao & Liping Su. (2022) Management of adverse effects associated with pegylated Escherichia coli asparaginase on coagulation in the treatment of patients with NK/T-cell lymphoma. Medicine 101:10, pages e25578.
Crossref
Crossref
Mauro Pagani, Sevim Bavbek, Emilio Alvarez‐Cuesta, Adile Berna Dursun, Patrizia Bonadonna, Mariana Castells, Josefina Cernadas, Anca Chiriac, Hamadi Sahar, Ricardo Madrigal‐Burgaleta & Soledad Sanchez Sanchez. (2021) Hypersensitivity reactions to chemotherapy: an EAACI Position Paper. Allergy 77:2, pages 388-403.
Crossref
Crossref
Katarzyna Derwich, Adam BrzezinskiCorrinna KarpenkoVanisha MorarUdani Atukoralalage. (2022) Acute Lymphoblastic Leukemia in Adolescents and Young Adults: A Polish Perspective. Journal of Adolescent and Young Adult Oncology 11:1, pages 1-5.
Crossref
Crossref
Chen-xi Liu, Yun-yu Zhang, Qiu-shi Yang, Shu-hong Shen, Jing Chen, Yan-jing Tang, Chang-cheng Chen, Zhuo Wang, Bi-ru Li, Juan Qian, Ying Wang, Wen-ting Hu & Bo-tao Ning. (2022) Asparaginase-associated pancreatitis in chemotherapy- treated pediatric patients: a five-year retrospective study. World Journal of Emergency Medicine 13:4, pages 313.
Crossref
Crossref
Songpon Getsuwan, Pornthep Tanpowpong, Chatmanee Lertudomphonwanit, Thitiporn Junhasavasdikul, Thipwimol Tim‐Aroon & Suporn Treepongkaruna. (2022) Etiology and outcome of acute recurrent pancreatitis and chronic pancreatitis. Pediatrics International 64:1.
Crossref
Crossref
Lucie Safrhansova, Katerina Hlozkova & Julia Starkova. 2022. Nutrition and Cancer. Nutrition and Cancer
37
79
.
Ajay GuptaRahul C. DamaniaRavi TalatiMary Ann O'RiordanYousif H. MatloubSanjay P. Ahuja. (2021) Increased Toxicity Among Adolescents and Young Adults Compared with Children Hospitalized with Acute Lymphoblastic Leukemia at Children's Hospitals in the United States. Journal of Adolescent and Young Adult Oncology 10:6, pages 645-653.
Crossref
Crossref
Gundala Venkata Naveen Kumar, Keito Hoshitsuki, Sanjay Rathod, Manda J. Ramsey, Lauren Kokai, Erin E. Kershaw, Wen Xie & Christian A. Fernandez. (2021) Mechanistic studies of PEG-asparaginase-induced liver injury and hepatic steatosis in mice. Acta Pharmaceutica Sinica B 11:12, pages 3779-3790.
Crossref
Crossref
Roxana Silvia Bumbacea, Selda Ali, Sabina Loredana Corcea, Luiza Spiru, Cornelia Nitipir, Victor Strambu & Dragos Bumbacea. (2021) Omalizumab for successful chemotherapy desensitisation: What we know so far. Clinical and Translational Allergy 11:10.
Crossref
Crossref
Kjeld Schmiegelow, Cecilie Utke Rank, Wendy Stock, Emily Dworkin & Inge van der Sluis. (2021) SOHO State of the Art Updates and Next Questions: Management of Asparaginase Toxicity in Adolescents and Young Adults with Acute Lymphoblastic Leukemia. Clinical Lymphoma Myeloma and Leukemia 21:11, pages 725-733.
Crossref
Crossref
Rachael Schulte, Ashley Hinson, Van Huynh, Erin H. Breese, Joanna Pierro, Seth Rotz, Benjamin A. Mixon, Jennifer L. McNeer, Michael J. Burke & Etan Orgel. (2021) Levocarnitine for pegaspargase‐induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia. Cancer Medicine 10:21, pages 7551-7560.
Crossref
Crossref
Christina Salvador, Robert Salvador, Peter Willeit, Christine Kuntner, Alexandra Haid, Thomas Müller, Gabriele Kropshofer & Roman Crazzolara. (2021) Hyponatremia During Induction Therapy in Distinct Pediatric Oncological Cohorts: A Retrospective Study. Frontiers in Oncology 11.
Crossref
Crossref
Amber Gibson, Carlos Hernandez, Fiorela N. Hernandez Tejada, Jitesh Kawedia, Michael Rytting & Branko Cuglievan. (2021) Asparaginase-Associated Pancreatitis in Pediatric Patients with Acute Lymphoblastic Leukemia: Current Perspectives. Pediatric Drugs 23:5, pages 457-463.
Crossref
Crossref
David O. Riley, Jenna M. Schlefman, Hans Christoph Vitzthum Von Eckstaedt V, Amy L. Morris, Michael K. Keng & Firas El Chaer. (2021) Pegaspargase in Practice: Minimizing Toxicity, Maximizing Benefit. Current Hematologic Malignancy Reports 16:3, pages 314-324.
Crossref
Crossref
Sarah M. Kashanian, Noa G. Holtzman, Ciera L. Patzke, Jonathan Cornu, Alison Duffy, Madhurima Koka, Sandrine Niyongere, Vu H. Duong, Maria R. Baer, Jummai Apata, Farin Kamangar & Ashkan Emadi. (2021) Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens. Cancer Chemotherapy and Pharmacology 87:6, pages 817-826.
Crossref
Crossref
Manuela Tosi, Orietta Spinelli, Matteo Leoncin, Roberta Cavagna, Chiara Pavoni, Federico Lussana, Tamara Intermesoli, Luca Frison, Giulia Perali, Francesca Carobolante, Piera Viero, Cristina Skert, Alessandro Rambaldi & Renato Bassan. (2021) MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL. Cancers 13:9, pages 2108.
Crossref
Crossref
Ilja Dubinski, Tobias Feuchtinger, Esther Maier, Moritz Tacke & Florian Hoffmann. (2021) Transient Hyperammonemic Encephalopathy in a Child with Relapsed Acute Lymphoblastic Leukemia and Severe Tumor Lysis Syndrome. Journal of Child Science 11:01, pages e208-e211.
Crossref
Crossref
Justin Darrah & Weili Sun. 2021. Biology and Treatment of Leukemia and Bone Marrow Neoplasms. Biology and Treatment of Leukemia and Bone Marrow Neoplasms
75
96
.
Federico Lussana, Paola Minetto, Felicetto Ferrara, Sabina Chiaretti, Giorgina Specchia & Renato Bassan. (2020) National Italian Delphi panel consensus: which measures are indicated to minimize pegylated-asparaginase associated toxicity during treatment of adult acute lymphoblastic leukemia?. BMC Cancer 20:1.
Crossref
Crossref
Hassan Sibai, Ruiqi Chen, Xing Liu, Umberto Falcone, Aaron Schimmer, Andre Schuh, Arjun Law, Caroline McNamara, Dawn Maze, Karen Yee, Mark Minden, Steven M. Chan, Vikas Gupta, Tracy Murphy, Naoko Sakurai, Eshetu G. Atenafu, Joseph M. Brandwein & Jack T. Seki. (2020) Anticoagulation prophylaxis reduces venous thromboembolism rate in adult acute lymphoblastic leukaemia treated with asparaginase‐based therapy. British Journal of Haematology 191:5, pages 748-754.
Crossref
Crossref
Laura Olivier‐Gougenheim, Chloe Arfeuille, Stefan Suciu, Nicolas Sirvent, Geneviève Plat, Alina Ferster, Barbara de Moerloose, Carine Domenech, Anne Uyttebroeck, Pierre‐Simon Rohrlich, Helene Cavé & Yves Bertrand. (2020) Pediatric randomized trial EORTC CLG 58951: Outcome for adolescent population with acute lymphoblastic leukemia. Hematological Oncology 38:5, pages 763-772.
Crossref
Crossref
Laura Hinze, Roxane Labrosse, James Degar, Teng Han, Emma M. Schatoff, Sabine Schreek, Salmaan Karim, Connor McGuckin, Joshua R. Sacher, Florence Wagner, Martin Stanulla, Chen Yuan, Ewa Sicinska, Marios Giannakis, Kimmie Ng, Lukas E. Dow & Alejandro Gutierrez. (2020) Exploiting the Therapeutic Interaction of WNT Pathway Activation and Asparaginase for Colorectal Cancer Therapy. Cancer Discovery 10:11, pages 1690-1705.
Crossref
Crossref
Yun-yu Zhang, Qiu-shi Yang, Xia Qing, Bi-ru Li, Juan Qian, Ying Wang & Bo-tao Ning. (2020) Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study. Frontiers in Oncology 10.
Crossref
Crossref
Mark B. Geyer, Ellen K. Ritchie, Arati V. Rao, Shreya Vemuri, Jessica Flynn, Meier Hsu, Sean M. Devlin, Mikhail Roshal, Qi Gao, Madhulika Shukla, Jose M. Salcedo, Peter Maslak, Martin S. Tallman, Dan Douer & Jae H. Park. (2020) Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromosome-negative acute lymphoblastic leukemia. Haematologica 106:8, pages 2086-2094.
Crossref
Crossref
Cecilie U Rank, Line Stensig Lynggaard, Bodil Als-Nielsen, Wendy Stock, Nina Toft, Ove Juul Nielsen, Thomas Leth Frandsen, Ruta Tuckuviene & Kjeld Schmiegelow. (2020) Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia. Cochrane Database of Systematic Reviews 2020:10.
Crossref
Crossref
Shlomit Barzilai-Birenboim, Ronit Nirel, Nira Arad-Cohen, Galia Avrahami, Miri Ben Harush, Assaf Barg, Bella Bielorai, Ronit Elhasid, Gil Gilad, Amos Toren, Sigal Weinreb, Shai Izraeli & Sarah Elitzur. (2020) Venous Thromboembolism and Its Risk Factors in Children with Acute Lymphoblastic Leukemia in Israel: A Population-Based Study. Cancers 12:10, pages 2759.
Crossref
Crossref
Firas El Chaer & Karen K. Ballen. (2019) Treatment of acute leukaemia in adult Jehovah's Witnesses. British Journal of Haematology 190:5, pages 696-707.
Crossref
Crossref
Hesham Saeed, Asmaa Hemida, Nefertiti El-Nikhely, Manal Abdel-Fattah, Manal Shalaby, Ahmed Hussein, Ahmad Eldoksh, Farid Ataya, Nihal Aly, Nikolaos Labrou & Hisham Nematalla. (2020) Highly efficient Pyrococcus furiosus recombinant L-asparaginase with no glutaminase activity: Expression, purification, functional characterization, and cytotoxicity on THP-1, A549 and Caco-2 cell lines. International Journal of Biological Macromolecules 156, pages 812-828.
Crossref
Crossref
Wellington F. da Silva, Ires H.B. Massaut, Rodrigo M. Bendlin, Lidiane I. Rosa, Elvira D.R.P. Velloso, Eduardo M. Rego & Vanderson Rocha. (2020) Toxicity Profile of PEG-Asparaginase in Adult Patients With Acute Lymphoblastic Leukemia in Brazil: A Multicenter Cross-Sectional Study. Clinical Lymphoma Myeloma and Leukemia 20:8, pages e523-e528.
Crossref
Crossref
Joselle Cook & Mark Litzow. (2020) Advances in Supportive Care for Acute Lymphoblastic Leukemia. Current Hematologic Malignancy Reports 15:4, pages 276-293.
Crossref
Crossref
Cecilie Utke Rank & Kjeld Schmiegelow. (2020) Optimal approach to the treatment of young adults with acute lymphoblastic leukemia in 2020. Seminars in Hematology 57:3, pages 102-114.
Crossref
Crossref
Gemlyn George, Alexandra Rezazadeh, Felicia Zook, Nicole Pearl, Cole McCoy, Karen Carlson, Lyndsey Runaas, Sameem Abedin, Guru Subramanian Guru Murthy, Laura C. Michaelis, Ehab Atallah & Lisa Baumann-Kreuziger. (2020) Reducing venous thrombosis with antithrombin supplementation in patients undergoing treatment for ALL with Peg-asparaginase—A real world study. Leukemia Research 94, pages 106368.
Crossref
Crossref
Sumit Gupta, Cindy Wang, Elizabeth A. Raetz, Reuven Schore, Wanda L. Salzer, Eric C. Larsen, Kelly W. Maloney, Len A. MattanoJrJr, William L. Carroll, Naomi J. Winick, Stephen P. Hunger, Mignon L. Loh & Meenakshi Devidas. (2020) Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children’s Oncology Group. Journal of Clinical Oncology 38:17, pages 1897-1905.
Crossref
Crossref
Ahmet Ulu, Muhammet Karaman, Fatma Yapıcı, Mehmet Naz, Selin Sayın, Eyüp İlker Saygılı & Burhan Ateş. (2019) The Carboxylated Multi-walled Carbon Nanotubes/l-Asparaginase Doped Calcium-Alginate Beads: Structural and Biocatalytic Characterization. Catalysis Letters 150:6, pages 1679-1691.
Crossref
Crossref
Chun Li, Zhi-Jun Wuxiao, Xiaoqin Chen, Guanjun Chen, Yue Lu, Zhongjun Xia, Yang Liang & Hua Wang. (2020) A Modified NHL-BFM-95 Regimen Produces Better Outcome Than HyperCVAD in Adult Patients with T-Lymphoblastic Lymphoma, a Two-Institution Experience. Cancer Research and Treatment 52:2, pages 573-585.
Crossref
Crossref
J. Fulcher & M. Carrier. (2020) Thromboembolism prophylaxis during L-asparaginase therapy in acute lymphoblastic leukemia – time to reconsider current approaches?. Thrombosis Research 188, pages 100-102.
Crossref
Crossref
Caitlin R. Rausch, Elias J. Jabbour, Hagop M. Kantarjian & Tapan M. Kadia. (2019) Optimizing the use of the hyperCVAD regimen: Clinical vignettes and practical management. Cancer 126:6, pages 1152-1160.
Crossref
Crossref
Jeffrey I. Zwicker, Tzu‐Fei Wang, Daniel J. DeAngelo, Mandy N. Lauw, Jean M. Connors, Anna Falanga, Malgorzata McMasters & Marc Carrier. (2020) The prevention and management of asparaginase‐related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH. Journal of Thrombosis and Haemostasis 18:2, pages 278-284.
Crossref
Crossref
Ibrahim Aldoss & Dan Douer. (2020) How I Treat the Toxicities of Pegasparaginase in Adults with Acute Lymphoblastic Leukemia. Blood.
Crossref
Crossref
Ruo-Jing Li, Runyan Jin, Chao Liu, Xianhua Cao, Michael L. Manning, Xu Michael Di, Donna Przepiorka, Frances Namuswe, Albert Deisseroth, Kirsten B. Goldberg, Gideon M. Blumenthal & Richard Pazdur. (2020) FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults. Clinical Cancer Research 26:2, pages 328-331.
Crossref
Crossref
Cecilie U. Rank, Benjamin O. Wolthers, Kathrine Grell, Birgitte K. Albertsen, Thomas L. Frandsen, Ulrik M. Overgaard, Nina Toft, Ove J. Nielsen, Peder S. Wehner, Arja Harila-Saari, Mats M. Heyman, Johan Malmros, Jonas Abrahamsson, Ulrika Norén-Nyström, Beata Tomaszewska-Toporska, Bendik Lund, Kirsten B. Jarvis, Petter Quist-Paulsen, Goda E. Vaitkevičienė, Laimonas Griškevičius, Mervi Taskinen, Ulla Wartiovaara-Kautto, Kristi Lepik, Mari Punab, Ólafur G. Jónsson & Kjeld Schmiegelow. (2020) Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age. Journal of Clinical Oncology 38:2, pages 145-154.
Crossref
Crossref
Hope D. Swanson, John C. Panetta, Patricia J. Barker, Yiwei Liu, Hiroto Inaba, Mary V. Relling, Ching-Hon Pui & Seth E. Karol. (2020) Predicting success of desensitization after pegaspargase allergy. Blood 135:1, pages 71-75.
Crossref
Crossref
Francesca Carobolante, Sabina Chiaretti, Cristina Skert & Renato Bassan. (2020) Practical guidance for the management of acute lymphoblastic leukemia in the adolescent and young adult population. Therapeutic Advances in Hematology 11, pages 204062072090353.
Crossref
Crossref
Najeebah A Bade, Crystal Lu, Ciera L Patzke, Maria R Baer, Vu H Duong, Jennie Y Law, Seung T Lee, Edward A Sausville, Ann B Zimrin, Alison P Duffy, Justin Lawson & Ashkan Emadi. (2019) Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and management. Journal of Oncology Pharmacy Practice 26:1, pages 74-92.
Crossref
Crossref
Kimberly M Lau, Ila M Saunders & Aaron Goodman. (2019) Pegaspargase-induced hypertriglyceridemia in a patient with acute lymphoblastic leukemia. Journal of Oncology Pharmacy Practice 26:1, pages 193-199.
Crossref
Crossref
Patrick W. Burke, Dieter Hoelzer, Jae H. Park, Kjeld Schmiegelow & Dan Douer. (2020) Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion. ESMO Open 5:5, pages e000858.
Crossref
Crossref
Lori Muffly & Emily Curran. (2019) Pediatric-inspired protocols in adult acute lymphoblastic leukemia: are the results bearing fruit?. Hematology 2019:1, pages 17-23.
Crossref
Crossref
Marlise R. Luskin & Daniel J. DeAngelo. (2019) T‐cell acute lymphoblastic leukemia: Current approach and future directions. ADVANCES IN CELL AND GENE THERAPY 2:4.
Crossref
Crossref
Natasha Kamal, Christopher Koh, Niharika Samala, Robert J. Fontana, Andrew Stolz, Francisco Durazo, Paul H. Hayashi, Elizabeth Phillips, Tongrong Wang & Jay H. Hoofnagle. (2019) Asparaginase-induced hepatotoxicity: rapid development of cholestasis and hepatic steatosis. Hepatology International 13:5, pages 641-648.
Crossref
Crossref
Sumant Arora, Jagpal Klair, Andrew M. Bellizzi & Tomohiro Tanaka. (2019) L-carnitine and Vitamin B Complex for PEG-L-asparaginase-Induced Hepatotoxicity. ACG Case Reports Journal 6:8, pages e00194.
Crossref
Crossref
Yiwei Liu, Colton A. Smith, John C. Panetta, Wenjian Yang, Lauren E. Thompson, Jacob P. Counts, Alejandro R. Molinelli, Deqing Pei, Nancy M. Kornegay, Kristine R. Crews, Hope Swanson, Cheng Cheng, Seth E. Karol, William E. Evans, Hiroto Inaba, Ching-Hon Pui, Sima Jeha & Mary V. Relling. (2019) Antibodies Predict Pegaspargase Allergic Reactions and Failure of Rechallenge. Journal of Clinical Oncology 37:23, pages 2051-2061.
Crossref
Crossref
Lisandra Herrera Belén, Jorge Beltrán Lissabet, Carlota de Oliveira Rangel-Yagui, Brian Effer, Gisele Monteiro, Adalberto Pessoa & Jorge G. Farías Avendaño. (2019) A structural in silico analysis of the immunogenicity of l-asparaginase from Escherichia coli and Erwinia carotovora. Biologicals 59, pages 47-55.
Crossref
Crossref
Young-A. Heo, Yahiya Y. Syed & Susan J. Keam. (2019) Pegaspargase: A Review in Acute Lymphoblastic Leukaemia. Drugs 79:7, pages 767-777.
Crossref
Crossref
Michael Losasso, Bruce Bostrom & Yoav Messinger. (2020) Retrospective cohort study monitoring PEG-asparaginase activity in acute lymphoblastic leukemia patients with and without premedication. F1000Research 8, pages 1007.
Crossref
Crossref
Michael Losasso, Bruce Bostrom & Yoav Messinger. (2019) Retrospective cohort study monitoring PEG-asparaginase activity in acute lymphoblastic leukemia patients with and without premedication. F1000Research 8, pages 1007.
Crossref
Crossref
Wen Zheng, Yuhuan Gao, Xiaoyan Ke, Weijing Zhang, Liping Su, Hanyun Ren, Ningjing Lin, Yan Xie, Meifeng Tu, Weiping Liu, Lingyan Ping, Zhitao Ying, Chen Zhang, Lijuan Deng, Xiaopei Wang, Yuqin Song & Jun Zhu. (2018) PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity. BMC Cancer 18:1.
Crossref
Crossref
Stuart E. Siegel, Anjali Advani, Nita Seibel, Lori Muffly, Wendy Stock, Selina Luger, Bijal Shah, Daniel J. DeAngelo, David R. Freyer, Dan Douer, Rebecca H. Johnson, Brandon Hayes-Lattin, Mark Lewis, Jerry J. Jaboin, Peter F. Coccia & Archie Bleyer. (2018) Treatment of young adults with Philadelphia-negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper-CVAD vs. pediatric-inspired regimens. American Journal of Hematology 93:10, pages 1254-1266.
Crossref
Crossref
Frank DiPaola & Jean P. Molleston. (2018) Drug-Induced Liver Injury in Children. Current Hepatology Reports 17:3, pages 283-291.
Crossref
Crossref
Megan Peters, Janine Zee-Cheng, Ashley Kuhl, Jennifer Orozco, Everett Lally & Jessica Scott Schwoerer. (2018) Pegylated asparaginase as cause of fatal hyperammonemia in patients with latent urea cycle disorder. Pediatric Blood & Cancer 65:9, pages e27239.
Crossref
Crossref
Françoise HuguetSylvie ChevretThibaut LeguayXavier ThomasNicolas BoisselMartine Escoffre-BarbePatrice ChevallierMathilde HunaultNorbert VeyCaroline BonmatiStéphane LepretreJean-Pierre MarolleauThomas PabstPhilippe RousselotAgnès BuzynJean-Yves CahnVéronique LhéritierMarie C. BénéVahid AsnafiEric DelabesseElizabeth MacintyreYves ChalandonNorbert IfrahHervé Dombret. (2018) Intensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical Trial. Journal of Clinical Oncology 36:24, pages 2514-2523.
Crossref
Crossref
Nicolas Boissel & André Baruchel. (2018) Acute lymphoblastic leukemia in adolescent and young adults: treat as adults or as children?. Blood 132:4, pages 351-361.
Crossref
Crossref
Hyun Jee Kim, Chan-Young Ock, Tae Min Kim, Sung Hee Lee, Ju-Yeun Lee, Sun hoi Jung, Yoon Sook Cho, Miso Kim, Bhumsuk Keam, Dong-Wan Kim, Il Han Kim & Dae Seog Heo. (2018) Comparison of Native Escherichia coli L-Asparaginase versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone, in Extranodal NK/T-Cell Lymphoma, Nasal Type. Cancer Research and Treatment 50:3, pages 670-680.
Crossref
Crossref
Alison Blackman, Alyssa Boutin, Alexei Shimanovsky, William J Baker & Nicholas Forcello. (2017) Levocarnitine and vitamin B complex for the treatment of pegaspargase-induced hepatotoxicity: A case report and review of the literature. Journal of Oncology Pharmacy Practice 24:5, pages 393-397.
Crossref
Crossref
Trevor N Christ, Wendy Stock & Randall W Knoebel. (2017) Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen. Journal of Oncology Pharmacy Practice 24:4, pages 299-308.
Crossref
Crossref
Jennifer L. McNeer & Archie Bleyer. (2018) Acute lymphoblastic leukemia and lymphoblastic lymphoma in adolescents and young adults. Pediatric Blood & Cancer 65:6.
Crossref
Crossref
Caitlin R. Rausch, Shilpa Paul, Kayleigh R. Marx, Elias Jabbour, Naveen Pemmaraju, Alessandra Ferrajoli & Hagop Kantarjian. (2018) L-carnitine and Vitamin B Complex for the Treatment of Pegasparaginase-induced Hyperbilirubinemia. Clinical Lymphoma Myeloma and Leukemia 18:5, pages e191-e195.
Crossref
Crossref
Hien Anh Nguyen, Ying Su, Jenny Y. Zhang, Aleksandar Antanasijevic, Michael Caffrey, Amanda M. Schalk, Li Liu, Damiano Rondelli, Annie Oh, Dolores L. Mahmud, Maarten C. Bosland, Andre Kajdacsy-Balla, Sofie Peirs, Tim Lammens, Veerle Mondelaers, Barbara De Moerloose, Steven Goossens, Michael J. Schlicht, Kasim K. Kabirov, Alexander V. Lyubimov, Bradley J. Merrill, Yogen Saunthararajah, Pieter Van Vlierberghe & Arnon Lavie. (2018)
A Novel
l
-Asparaginase with low
l
-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias
In Vivo
. Cancer Research 78:6, pages 1549-1560.
Crossref
Crossref
Yazeed Sawalha & Anjali S Advani. (2018) Management of older adults with acute lymphoblastic leukemia: challenges & current approaches. International Journal of Hematologic Oncology 7:1, pages IJH02.
Crossref
Crossref
Anil Kamat. (2018) Retrospective post-marketing study on the use of bio-similar pegasparagase among acute lymphoblastic leukemia patients in India. Pediatric Hematology Oncology Journal 3:1, pages 9-12.
Crossref
Crossref
Patrick W. Burke, Ibrahim Aldoss, Matthew A. Lunning, Sean M. Devlin, Martin S. Tallman, Vinod Pullarkat, Ann M. Mohrbacher & Dan Douer. (2018) Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with subsequent doses. Leukemia Research 66, pages 49-56.
Crossref
Crossref
Mauro Pagani. (2018) Options in Hypersensitivity Reactions to Chemotherapeutics. Current Treatment Options in Allergy 5:1, pages 118-132.
Crossref
Crossref
Nicola Gökbuget & Dieter Hoelzer. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
337
357
.
Jessica Leonard & Wendy Stock. (2017) Progress in adult ALL: incorporation of new agents to frontline treatment. Hematology 2017:1, pages 28-36.
Crossref
Crossref
Ofir Wolach, Irina Amitai & Daniel J. DeAngelo. (2017) Current challenges and opportunities in treating adult patients with Philadelphia-negative acute lymphoblastic leukaemia. British Journal of Haematology 179:5, pages 705-723.
Crossref
Crossref
Jiabao Liang, Pengcheng Shi, Xutao Guo, Jie Li, Lingli He, Yan Wang, Qi Wei, Fen Huang, Zhiping Fan & Bing Xu. (2017) A retrospective comparison of Escherichia�coli and polyethylene glycol‑conjugated asparaginase for the treatment of adolescents and adults with newly diagnosed acute lymphoblastic leukemia. Oncology Letters.
Crossref
Crossref
Van Thu Huynh & Sharon Bergeron. (2017) Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia
. Clinical Journal of Oncology Nursing 21:5, pages E248-E259.
Crossref
Crossref
Kyung Mi Ko & Hyen O La. (2017) Analysis of L-asparaginase Related Adverse Reaction. Korean Journal of Clinical Pharmacy 27:3, pages 143-149.
Crossref
Crossref
Bernard L. Marini, Anthony J. Perissinotti, Dale L. Bixby, Julia Brown & Patrick W. Burke. (2017) Catalyzing improvements in ALL therapy with asparaginase. Blood Reviews 31:5, pages 328-338.
Crossref
Crossref
Nicolas Boissel. (2017) How should we treat the AYA patient with newly diagnosed ALL?. Best Practice & Research Clinical Haematology.
Crossref
Crossref
Y Liu, CA Fernandez, C Smith, W Yang, C Cheng, JC Panetta, N Kornegay, C Liu, LB Ramsey, SE Karol, LJ Janke, EC Larsen, N Winick, WL Carroll, ML Loh, EA Raetz, SP Hunger, M Devidas, JJ Yang, CG Mullighan, J Zhang, WE Evans, S Jeha, C-H Pui & MV Relling. (2017)
Genome-Wide Study Links
PNPLA3
Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy
. Clinical Pharmacology & Therapeutics 102:1, pages 131-140.
Crossref
Crossref
H Alachkar, N Fulton, B Sanford, G Malnassy, M Mutonga, R A Larson, C D Bloomfield, G Marcucci, Y Nakamura & W Stock. (2016) Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemia. The Pharmacogenomics Journal 17:3, pages 274-279.
Crossref
Crossref
Ankit Kansagra & Mark Litzow. (2017) Treatment of Young Adults with Acute Lymphoblastic Leukemia. Current Hematologic Malignancy Reports 12:3, pages 187-196.
Crossref
Crossref
Maria Lopez-Santillan, Leire Iparraguirre, Idoia Martin-Guerrero, Angela Gutierrez-Camino & Africa Garcia-Orad. (2017)
Review of pharmacogenetics studies of L-asparaginase hypersensitivity in acute lymphoblastic leukemia points to variants in the
GRIA1
gene
. Drug Metabolism and Personalized Therapy 32:1, pages 1-9.
Crossref
Crossref
Gregory F. GuzauskasKathleen F. VillaGeertrui F. VanhoveVicki L. FisherDavid L. Veenstra. (2017) Risk–Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young Adults. Journal of Adolescent and Young Adult Oncology 6:1, pages 53-61.
Crossref
Crossref
Pere Barba, José Luis Dapena, Pau Montesinos & Susana Rives. (2017) Asparaginasas en el tratamiento de la leucemia linfoblástica aguda. Medicina Clínica 148:5, pages 225-231.
Crossref
Crossref
Pere Barba, José Luis Dapena, Pau Montesinos & Susana Rives. (2017) Asparaginase use for the treatment of acute lymphoblastic leukemia. Medicina Clínica (English Edition) 148:5, pages 225-231.
Crossref
Crossref
B O Wolthers, T L Frandsen, J Abrahamsson, B K Albertsen, L R Helt, M Heyman, Ó G Jónsson, L T Kõrgvee, B Lund, R A Raja, K K Rasmussen, M Taskinen, M Tulstrup, G E Vaitkevičienė, R Yadav, R Gupta & K Schmiegelow. (2016) Asparaginase-associated pancreatitis: a study on phenotype and genotype in the NOPHO ALL2008 protocol. Leukemia 31:2, pages 325-332.
Crossref
Crossref
B Patel, A A Kirkwood, A Dey, D I Marks, A K McMillan, T F Menne, L Micklewright, P Patrick, S Purnell, C J Rowntree, P Smith & A K Fielding. (2016) Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial. Leukemia 31:1, pages 58-64.
Crossref
Crossref
Jennifer L. McNeer, Archie Bleyer, Valentino Conter & Wendy Stock. 2017. Cancer in Adolescents and Young Adults. Cancer in Adolescents and Young Adults
151
175
.
Wen-jian Liu, Hua Wang, Wei-da Wang, Meng-yuan Zhu, Cheng-cheng Liu, Jing-hua Wang & Yue Lu. (2016) Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective single-center study. Scientific Reports 6:1.
Crossref
Crossref
Troy Z. Horvat, Joshua J. Pecoraro, Ryan J. Daley, Larry W. Buie, Amber C. King, Raajit K. Rampal, Martin S. Tallman, Jae H. Park & Dan Douer. (2016) The use of Erwinia asparaginase for adult patients with acute lymphoblastic leukemia after pegaspargase intolerance. Leukemia Research 50, pages 17-20.
Crossref
Crossref
Vilmarie Rodriguez, John Kairalla, Wanda L. Salzer, Elizabeth A. Raetz, Mignon LC Loh, Andrew J. Carroll, Nyla A. Heerema, Brent L. Wood, Michael J. Borowitz, Michael J. Burke, Barbara L. Asselin, Meenakshi Devidas, Naomi J. Winick, William L. Carroll, Stephen P. Hunger & ZoAnn E. Dreyer. (2016) A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children’s Oncology Group Study AALL08P1. Journal of Pediatric Hematology/Oncology 38:6, pages 409-417.
Crossref
Crossref
Jing-hua Wang, Hua Wang, Yan-jun Wang, Zhong-jun Xia, Hui-qiang Huang, Wen-qi Jiang & Yue Lu. (2016) Analysis of the efficacy and safety of a combined gemcitabine, oxaliplatin and pegaspargase regimen for NK/T-cell lymphoma. Oncotarget 7:23, pages 35412-35422.
Crossref
Crossref
Jing-hua Wang, Liang Wang, Cheng-cheng Liu, Zhong-jun Xia, Hui-qiang Huang, Tong-yu Lin, Wen-qi Jiang & Yue Lu. (2016) Efficacy of combined gemcitabine, oxaliplatin and pegaspargase (P-gemox regimen) in patients with newly diagnosed advanced-stage or relapsed/refractory extranodal NK/T-cell lymphoma. Oncotarget 7:20, pages 29092-29101.
Crossref
Crossref
Xavier Thomas & Caroline Le Jeune. (2016)
Erythrocyte encapsulated
l
-asparaginase (GRASPA) in acute leukemia
. International Journal of Hematologic Oncology 5:1, pages 11-25.
Crossref
Crossref
Rodolfo J. Galindo, Justin Yoon, Craig Devoe & Alyson K. Myers. (2016) PEG-asparaginase induced severe hypertriglyceridemia. Archives of Endocrinology and Metabolism 60:2, pages 173-177.
Crossref
Crossref
Ibrahim Aldoss, Dan Douer, Carolyn E. Behrendt, Preeti Chaudhary, Ann Mohrbacher, Janice Vrona & Vinod Pullarkat. (2016) Toxicity profile of repeated doses of PEG-asparaginase incorporated into a pediatric-type regimen for adult acute lymphoblastic leukemia. European Journal of Haematology 96:4, pages 375-380.
Crossref
Crossref
Muaz Alrazzak, Lynda K. Beaupin, Peter Kinyoun & Matthew Barth. (2016) The Incidence of Hypersensitivity Reactions to Pegylated Asparaginase in Children With Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology 38:1, pages e16-e20.
Crossref
Crossref
Jean-Baptiste Bachet, Fabien Gay, Raphaël Maréchal, Marie-Pierre Galais, Antoine Adenis, David Salako, MsC, Jerome Cros, Pieter Demetter, Magali Svrcek, Armelle Bardier-Dupas, Jean-François Emile, Pascal Hammel, Christelle Ebenezer, Willy Berlier, Yann Godfrin & Thierry André. (2015) Asparagine Synthetase Expression and Phase I Study With L-Asparaginase Encapsulated in Red Blood Cells in Patients With Pancreatic Adenocarcinoma. Pancreas 44:7, pages 1141-1147.
Crossref
Crossref
Nicolas BoisselLeonard S. Sender. (2015) Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on Asparaginase. Journal of Adolescent and Young Adult Oncology 4:3, pages 118-128.
Crossref
Crossref
R. Berrueco, A. Alonso-Saladrigues, L. Martorell-Sampol, A. Català-Temprano, A. Ruiz-Llobet, T. Toll, M. Torrebadell, M. Naudó, M. Camós & S. Rives. (2015) Outcome and toxicities associated to chemotherapy in children with acute lymphoblastic leukemia and Gilbert syndrome. Usefulness of UGT1A1 mutational screening. Pediatric Blood & Cancer 62:7, pages 1195-1201.
Crossref
Crossref
Emily Curran & Wendy Stock. (2015) How I treat acute lymphoblastic leukemia in older adolescents and young adults. Blood 125:24, pages 3702-3710.
Crossref
Crossref
Peter H. Shaw, Damon R. Reed, Nicholas Yeager, Bradley Zebrack, Sharon M. Castellino & Archie Bleyer. (2015) Adolescent and Young Adult (AYA) Oncology in the United States. Journal of Pediatric Hematology/Oncology 37:3, pages 161-169.
Crossref
Crossref
Mustafa R. BashirXiaodong ZhongMarcel D. NickelGhaneh FananapazirStephan A. R. KannengiesserBerthold KieferBrian M. Dale. (2015) Quantification of Hepatic Steatosis With a Multistep Adaptive Fitting MRI Approach: Prospective Validation Against MR Spectroscopy. American Journal of Roentgenology 204:2, pages 297-306.
Crossref
Crossref
Michael J Burke. (2014) How to manage asparaginase hypersensitivity in acute lymphoblastic leukemia. Future Oncology 10:16, pages 2615-2627.
Crossref
Crossref
Xiaodong Zhong, Marcel D. Nickel, Stephan A.R. Kannengiesser, Brian M. Dale, Berthold Kiefer & Mustafa R. Bashir. (2014) Liver fat quantification using a multi-step adaptive fitting approach with multi-echo GRE imaging. Magnetic Resonance in Medicine 72:5, pages 1353-1365.
Crossref
Crossref
Carmelo Rizzari, Maria Caterina Putti, Antonella Colombini, Sara Casagranda, Giulia Maria Ferrari, Cristina Papayannidis, Ilaria Iacobucci, Maria Chiara Abbenante, Chiara Sartor & Giovanni Martinelli. (2014) Rationale for a Pediatric-Inspired Approach in the Adolescent and Young Adult Population with Acute Lymphoblastic Leukemia, with a Focus on Asparaginase Treatment. Hematology Reports 6:3, pages 5554.
Crossref
Crossref
Jitesh D. Kawedia & Michael E. Rytting. (2014) Asparaginase in Acute Lymphoblastic Leukemia. Clinical Lymphoma Myeloma and Leukemia 14, pages S14-S17.
Crossref
Crossref
Dan Douer. (2014) Will novel agents for ALL finally change the natural history?. Best Practice & Research Clinical Haematology 27:3-4, pages 247-258.
Crossref
Crossref
Brian A. Baldo & Mauro Pagani. (2014) Adverse Events to Nontargeted and Targeted Chemotherapeutic Agents. Immunology and Allergy Clinics of North America 34:3, pages 565-596.
Crossref
Crossref
FANG WU, LU QU, YAFEN TAN, YUE ZHANG & CHUNHONG HU. (2014) L-asparaginase-induced severe acute pancreatitis in an adult with extranodal natural killer/T-cell lymphoma, nasal type: A case report and review of the literature. Oncology Letters 7:4, pages 1305-1307.
Crossref
Crossref
Dan DouerIbrahim AldossMatthew A. LunningPatrick W. BurkeLaleh RamezaniLisa MarkJanice VronaJae H. ParkMartin S. TallmanVassilios I. AvramisVinod PullarkatAnn M. Mohrbacher. (2014) Pharmacokinetics-Based Integration of Multiple Doses of Intravenous Pegaspargase in a Pediatric Regimen for Adults With Newly Diagnosed Acute Lymphoblastic Leukemia. Journal of Clinical Oncology 32:9, pages 905-911.
Crossref
Crossref
Patrick W. Burke & Dan Douer. (2014) Acute Lymphoblastic Leukemia in Adolescents and Young Adults. Acta Haematologica 132:3-4, pages 264-273.
Crossref
Crossref
Gillian M. Keating. (2013) Asparaginase Erwinia chrysanthemi (Erwinaze®): A Guide to Its Use in Acute Lymphoblastic Leukemia in the USA. BioDrugs 27:4, pages 413-418.
Crossref
Crossref
Sara E. Shinnick, Mary L. Browning & Susannah E. Koontz. (2013) Managing Hypersensitivity to Asparaginase in Pediatrics, Adolescents, and Young Adults. Journal of Pediatric Oncology Nursing 30:2, pages 63-77.
Crossref
Crossref
Aleksandra Ciszewski & Thomas DeLoughery. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
1363
1385
.
Raheel Altaf Raja, Kjeld Schmiegelow & Thomas Leth Frandsen. (2012) Asparaginase‐associated pancreatitis in children. British Journal of Haematology 159:1, pages 18-27.
Crossref
Crossref
Tsila ZuckermanChezi Ganzel, Martin S. Tallman & Jacob M. Rowe. (2012) How I treat hematologic emergencies in adults with acute leukemia. Blood 120:10, pages 1993-2002.
Crossref
Crossref
Jennifer L. McNeer & Elizabeth A. Raetz. (2012) Acute lymphoblastic leukemia in young adults. Current Opinion in Oncology 24:5, pages 487-494.
Crossref
Crossref
Lori Muffly, Kristen Petit & Wendy Stock. (2012) Treating the younger adult with acute lymphoblastic leukemia. Clinical Practice 9:4, pages 439-449.
Crossref
Crossref
Taizo A. Nakano & Stephen P. Hunger. (2012) Blood consult: Therapeutic strategy and complications in the adolescent and young adult with acute lymphoblastic leukemia. Blood 119:19, pages 4372-4374.
Crossref
Crossref
Alexandre Chan, Tiffany Tang, Terence Ng, Vivianne Shih, Kevin Tay, Miriam Tao, Richard Quek & Soon Thye Lim. (2012) To SMILE or Not: Supportive Care Matters. Journal of Clinical Oncology 30:9, pages 1015-1016.
Crossref
Crossref
Jonathan Seah, Keegan Lin, David Tai, Soon T. Lim & Alexandre Chan. (2012) Conservative Management of L-Asparaginase-Induced Hypertriglyceridemia in an Adult Patient: A Case Report and Review of the Literature. Onkologie 35:10, pages 596-598.
Crossref
Crossref
Adele K. Fielding. (2011) Current Therapeutic Strategies in Adult Acute Lymphoblastic Leukemia. Hematology/Oncology Clinics of North America 25:6, pages 1255-1279.
Crossref
Crossref